Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticGraft SurvivalKidney TransplantationLeukemiaTissue DonorsTransplantation ChimeraLiver TransplantationBusulfanHistocompatibility TestingBone Marrow PurgingHistocompatibilityHematopoietic Stem CellsGraft RejectionCyclophosphamideTransplantation, IsogeneicImmunosuppressive AgentsBone Marrow DiseasesCombined Modality TherapyRecurrenceTreatment OutcomeTime FactorsMice, Inbred C57BLHematopoiesisHeart TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraLeukemia, Myeloid, AcuteHematologic NeoplasmsBone Marrow ExaminationImmunosuppressionTransplantation ImmunologyRetrospective StudiesSurvival AnalysisLung TransplantationRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsStem Cell TransplantationLeukemia, MyeloidGraft vs Host ReactionAcute DiseaseCyclosporineLymphocyte DepletionLymphoma, Non-HodgkinLeukocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesSurvival RateHLA AntigensT-LymphocytesColony-Forming Units AssaySevere Combined ImmunodeficiencyChimeraMyelodysplastic SyndromesFlow CytometryActuarial AnalysisBreast NeoplasmsMice, Inbred BALB CHematologic DiseasesCytomegalovirus InfectionsPrognosisDisease-Free SurvivalCell ProliferationTransplantationCell DifferentiationBone DensityLymphocyte TransfusionAntineoplastic AgentsNuclear FamilyNeoplasmsTransplantsCarmustineGraft vs Tumor EffectOrgan TransplantationEtoposidePancytopeniaGraft vs Leukemia EffectLeukocyte CountCytarabineApoptosisGranulocyte Colony-Stimulating FactorCells, CulturedMelphalanPostoperative ComplicationsAntibodies, MonoclonalSpleenLymphomaBone Neoplasms